TrialClinical pharmacokinetics2022

Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants.

Vidya Perera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.